LEON FRANCISCO (Chief Scientific Officer) sold 0.7% of their position (10.67K shares) of PROVENTION BIO, INC. on the open market
Open‑market sale worth $106.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2022ACC: 0001493152-22-036789
DirectorOfficer10% Owner· Chief Scientific Officer
Since Jul 2018
-10.67K
Net shares
Net seller
$106.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.67K acquired · 21.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.67K
Price / share
$2.50
Trade value
$26.68K
% of position
0.7%
12/27/2022
1.57M→1.58M
Common Stock
Direct
Shares
−10.67K
Price / share
$10.00
Trade value
$106.74K
% of position
0.7%
12/27/2022
1.58M→1.57M
Total
Net shares
+0.00
Net value
-$80.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/27/2022 | M · Option Exercise | +10.67K | $2.50 | $26.68K | 0.7% | 1.57M | 1.58M |
| Common Stock Direct | 12/27/2022 | S · Sale | −10.67K | $10.00 | $106.74K | 0.7% | 1.58M | 1.57M |
| Total | +0.00 | -$80.06K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10.67K shares
Shares
−10.67K
Strike price
2.5
Held after
529.10K
Exercisable
—
12/27/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10.67K shares | 12/27/2022 | M · Option Exercise | −10.67K | 2.5 | — | 529.10K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1M
Total
1M indirect1M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1M | Indirect |
| Total | 1M | 1M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported